
### [MONDO:0016117](http://purl.obolibrary.org/obo/MONDO_0016117)
**Label:** muscular lipidosis

**Subclasses:** [MONDO:0009282](http://purl.obolibrary.org/obo/MONDO_0009282) (multiple acyl-CoA dehydrogenase deficiency), [MONDO:0020504](http://purl.obolibrary.org/obo/MONDO_0020504) (genetic recurrent myoglobinuria), [MONDO:0015611](http://purl.obolibrary.org/obo/MONDO_0015611) (neutral lipid storage disease), [MONDO:0016810](http://purl.obolibrary.org/obo/MONDO_0016810) (autosomal recessive progressive external ophthalmoplegia), [MONDO:0010892](http://purl.obolibrary.org/obo/MONDO_0010892) (mitochondrial myopathy and sideroblastic anemia), [MONDO:0018002](http://purl.obolibrary.org/obo/MONDO_0018002) (adult-onset chronic progressive external ophthalmoplegia with mitochondrial myopathy), [MONDO:0008003](http://purl.obolibrary.org/obo/MONDO_0008003) (autosomal dominant progressive external ophthalmoplegia), [MONDO:0008722](http://purl.obolibrary.org/obo/MONDO_0008722) (short chain acyl-CoA dehydrogenase deficiency), [MONDO:0011835](http://purl.obolibrary.org/obo/MONDO_0011835) (sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome), [MONDO:0013028](http://purl.obolibrary.org/obo/MONDO_0013028) (adenosine monophosphate deaminase deficiency), [MONDO:0009637](http://purl.obolibrary.org/obo/MONDO_0009637) (mitochondrial myopathy), [MONDO:0015515](http://purl.obolibrary.org/obo/MONDO_0015515) (carnitine palmitoyltransferase II deficiency), 

**Corr. equiv. classes:** [Orphanet:26792](http://www.orpha.net/ORDO/Orphanet_26792), [OMIM:600462](http://purl.obolibrary.org/obo/OMIM_600462), [Orphanet:45](http://www.orpha.net/ORDO/Orphanet_45), [Orphanet:165](http://www.orpha.net/ORDO/Orphanet_165), [Orphanet:157](http://www.orpha.net/ORDO/Orphanet_157), [OMIM:157640](http://purl.obolibrary.org/obo/OMIM_157640), [OMIM:251900](http://purl.obolibrary.org/obo/OMIM_251900), [Orphanet:254892](http://www.orpha.net/ORDO/Orphanet_254892), [OMIM:607459](http://purl.obolibrary.org/obo/OMIM_607459), [Orphanet:254886](http://www.orpha.net/ORDO/Orphanet_254886), [OMIM:201470](http://purl.obolibrary.org/obo/OMIM_201470), [Orphanet:329336](http://www.orpha.net/ORDO/Orphanet_329336), [Orphanet:26791](http://www.orpha.net/ORDO/Orphanet_26791), [OMIM:612874](http://purl.obolibrary.org/obo/OMIM_612874), [Orphanet:70595](http://www.orpha.net/ORDO/Orphanet_70595), [Orphanet:99845](http://www.orpha.net/ORDO/Orphanet_99845), [Orphanet:206966](http://www.orpha.net/ORDO/Orphanet_206966), [Orphanet:2598](http://www.orpha.net/ORDO/Orphanet_2598), [OMIM:231680](http://purl.obolibrary.org/obo/OMIM_231680), 

**Class expressions from DL-Learner:**

- [HP:0003800](http://purl.obolibrary.org/obo/HP_0003800) (Muscle abnormality related to mitochondrial dysfunction) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) 55.42%
- [HP:0003800](http://purl.obolibrary.org/obo/HP_0003800) (Muscle abnormality related to mitochondrial dysfunction) and (not ([HP:0011458](http://purl.obolibrary.org/obo/HP_0011458) (Abdominal symptom))) 55.42%
- [HP:0003800](http://purl.obolibrary.org/obo/HP_0003800) (Muscle abnormality related to mitochondrial dysfunction) and (not ([HP:0004395](http://purl.obolibrary.org/obo/HP_0004395) (Malnutrition))) 55.42%
- [HP:0003800](http://purl.obolibrary.org/obo/HP_0003800) (Muscle abnormality related to mitochondrial dysfunction) and (not ([HP:0004326](http://purl.obolibrary.org/obo/HP_0004326) (Cachexia))) 55.42%
- [HP:0003800](http://purl.obolibrary.org/obo/HP_0003800) (Muscle abnormality related to mitochondrial dysfunction) and (not ([HP:0003828](http://purl.obolibrary.org/obo/HP_0003828) (Variable expressivity))) 55.42%
- [HP:0003800](http://purl.obolibrary.org/obo/HP_0003800) (Muscle abnormality related to mitochondrial dysfunction) and (not ([HP:0003593](http://purl.obolibrary.org/obo/HP_0003593) (Infantile onset))) 55.42%
- [HP:0003800](http://purl.obolibrary.org/obo/HP_0003800) (Muscle abnormality related to mitochondrial dysfunction) and (not ([HP:0001824](http://purl.obolibrary.org/obo/HP_0001824) (Weight loss))) 55.42%
- [HP:0003800](http://purl.obolibrary.org/obo/HP_0003800) (Muscle abnormality related to mitochondrial dysfunction) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 55.42%
- [HP:0003800](http://purl.obolibrary.org/obo/HP_0003800) (Muscle abnormality related to mitochondrial dysfunction) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) 55.42%
- [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) and [HP:0003800](http://purl.obolibrary.org/obo/HP_0003800) (Muscle abnormality related to mitochondrial dysfunction) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) 55.42%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) and [HP:0003800](http://purl.obolibrary.org/obo/HP_0003800) (Muscle abnormality related to mitochondrial dysfunction) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) 55.42%
- [HP:0003800](http://purl.obolibrary.org/obo/HP_0003800) (Muscle abnormality related to mitochondrial dysfunction) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 55.42%
- [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) and [HP:0003800](http://purl.obolibrary.org/obo/HP_0003800) (Muscle abnormality related to mitochondrial dysfunction) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 55.42%
- [HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis) and [HP:0003800](http://purl.obolibrary.org/obo/HP_0003800) (Muscle abnormality related to mitochondrial dysfunction) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) 55.42%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) and [HP:0003800](http://purl.obolibrary.org/obo/HP_0003800) (Muscle abnormality related to mitochondrial dysfunction) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) and [HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology) 55.42%


